RA in America 2014
Disease modifying therapies are intended to stop the progression of disease and prevent or reduce long-term damage to joints and related structures. Therefore, it’s not surprising that a vast majority of respondents – nearly 80% – started treatment for their RA within one month of receiving a diagnosis.
Nearly a quarter of respondents experienced RA flares on a daily basis. Another 50% noted that they experienced flares on a weekly or monthly basis.